Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

 

Drug Patent Expiration Newsletter - The following drugs face patent expirations in April 2006:
 

Applicant :: TRADENAME :: generic name

Gilead :: HEPSERA :: adefovir dipivoxil
Bristol Myers Squibb :: PRAVIGARD PAC (COPACKAGED) :: aspirin; pravastatin sodium
Gd Searle Llc :: INSPRA :: eplerenone
Serono Inc :: NOVANTRONE :: mitoxantrone hydrochloride
Bristol Myers Squibb :: PRAVACHOL :: pravastatin sodium

This list does not discriminate between dominant and non-dominant patents. Listed drugs above may be protected by additional patents and other regulatory protections.

For more details, visit DrugPatentWatch at http://www.DrugPatentWatch.com

To subscribe to the free Patent Expiration Bulletin, visit http://www.DrugPatentWatch.com/newsletter

Disclaimer:
All trademarks and applicant names are the property of their respective owners or licensors. Drug patent expiration data is presented "as is." Use of this information is at your own risk. No warranty is expressed or implied. There is no warranty that the drug patent expriation information is error free.

---
ABOUT DrugPatentWatch ( http://www.DrugPatentWatch.com )

DrugPatentWatch provides information on drug patent expirations. Complete details are provided for all FDA-approved small molecule drugs. Sales information is available for top-selling drugs. This value-added information supports the critical business functions of patent agents and attorneys, pharmaceutical companies, wholesalers, healthcare payers, and investors.


 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.